CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice.
Weber
C J
CJ
Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30308, USA.
Hagler
M K
MK
Chryssochoos
J T
JT
Larsen
C P
CP
Pearson
T C
TC
Jensen
P
P
Kapp
J A
JA
Linsley
P S
PS
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000627:therapeutic use*; D060908:CTLA-4 Antigen; D002214:Capsules; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D006085:Graft Survival; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D051379:Mice; D016688:Mice, Inbred NOD; D008863:Microspheres; D011817:Rabbits; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; D002214:Capsules; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept; D016572:Cyclosporine